CA
NZ
UK
AU
IND
US
Based in Tel Aviv, Enlivex develops Allocetra, an allogeneic, off-the-shelf cell-based immunotherapy designed to rebalance the immune system. Its lead indication is age-related symptomatic primary knee osteoarthritis in older patients. In July 2026 the company said Allocetra received U.S. Food and Drug Administration Regenerative …
Based in Phoenix, Arizona, Creative Medical Technology develops cell-based and immunotherapy products across regenerative medicine, immunology and urology. Its lead clinical asset is CELZ-201, also known as olastrocel, an allogeneic cell therapy being studied for chronic lower back pain caused by degenerative disc disease. …
SQZ Biotechnologies was a Massachusetts-based, clinical-stage company developing cell-engineering therapies using its proprietary "Cell Squeeze" platform, which momentarily deforms a cell's membrane to deliver antigens and other cargo, with lead programs in immuno-oncology. The company's most consequential recent development is procedural: SEC records show …
GelStat Corporation, incorporated in Delaware and based in Miami, is classified under pharmaceutical preparations and traces its corporate history back to an entity formerly named Developed Technology Resource Inc before adopting the GelStat name in 2003. Rather than filing standard 10-Ks and 10-Qs, GelStat …
Revelation Biosciences is developing Gemini, a phosphorylated hexaacyl disaccharide (PHAD)-based immunomodulator, with its lead program targeting acute kidney injury (AKI), a common and serious complication with few effective preventive therapies. The most recent verified milestone came on August 19, 2026, when Revelation said it …
Fulcrum Therapeutics is a Cambridge, Massachusetts clinical-stage biopharmaceutical company focused on small-molecule therapies for genetically defined diseases. For years its identity centered on losmapimod, an oral candidate for facioscapulohumeral muscular dystrophy (FSHD). That program suffered a decisive setback when its pivotal Phase 3 trial …
IDEXX Laboratories, based in Maine, is the global leader in veterinary diagnostics and software. Its largest business, the Companion Animal Group, sells in-clinic analyzers and their consumables, rapid SNAP tests and reference-laboratory services, creating a razor-and-blades model in which instrument placements drive years of …
cbdMD, based in Charlotte, North Carolina, markets consumer cannabidiol (CBD) products including tinctures, gummies, capsules and topicals, alongside a pet line under the Paw CBD brand. The company sells through e-commerce and retail channels and has positioned itself around wellness and quality. The most …
Allarity Therapeutics is a clinical-stage oncology company built around its Drug Response Predictor (DRP) platform, a genomic tool designed to select patients most likely to benefit from a given therapy. Its lead asset, stenoparib, is an orally available inhibitor being studied in advanced ovarian …
Aptevo Therapeutics, based in Seattle, is a clinical-stage biotechnology company developing bispecific antibodies through its ADAPTIR and ADAPTIR-FLEX platforms. Its lead candidate, mipletamig, is a T-cell-engaging bispecific designed to target CD123 in acute myeloid leukemia (AML), and the company has reported early clinical activity …
Please wait processing your request...